Clinical Trial: A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma

U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07392866) titled 'A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma' on Jan. 31.

Brief Summary: To evaluate the efficacy and safety of the combination therapy of SH006 injection in the treatment of advanced hepatocellular carcinoma

Study Start Date: March 01

Study Type: INTERVENTIONAL

Condition: Hepatocellular Carcinoma (HCC)

Intervention: DRUG: SH006

15 mg/kg administered as IV infusion on Day 1 of each 21-day cycle

DRUG: Bevacizumab

15 mg/kg administered as IV infusion on Day 1 of each 21-day cycle

DRUG: Oxaliplatin injection

85 mg/m2 administered as IV infu...